Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Dianne, Tomita"'
Autor:
Daisuke Honda, MD, PhD, Michihiro Hide, MD, PhD, Tomoo Fukuda, MD, PhD, Keisuke Koga, MD, PhD, Eishin Morita, MD, PhD, Shinichi Moriwaki, MD, Yoshihiro Sasaki, MD, PhD, Yusuke Suzuki, MD, PhD, Phil Collis, PhD, Douglas T. Johnston, DO, Dianne Tomita, MPH, Bhavisha Desai, PharmD, Isao Ohsawa, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 3, Pp 100882- (2024)
Background: Berotralstat is a once-daily oral inhibitor of plasma kallikrein for the prophylaxis of hereditary angioedema (HAE) in patients ≥12 years. APeX-J aimed to evaluate the efficacy and safety of berotralstat in Japan. Methods: APeX-J was a
Externí odkaz:
https://doaj.org/article/3b4e2445fcc64daeb7ca4e24132a6cc4
Autor:
Jonny G. Peter, MB ChB, MMed, FCP (SA), PhD, Bhavisha Desai, PharmD, Dianne Tomita, MPH, Phil Collis, PhD, Marcin Stobiecki, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 11, Pp 100841- (2023)
Background: Given the recent approval of oral berotralstat in several countries for hereditary angioedema (HAE) prophylaxis, transition from long-term androgens to berotralstat may occur in clinical practice. The open-label, Phase II APeX-S trial pro
Externí odkaz:
https://doaj.org/article/7c11ba56ee47471087615c15e26f3f19
Autor:
Daniel Soteres, William Lumry, Markus Magerl, Remi Gagnon, Bhavisha Desai, Dianne Tomita, Douglas Johnston, Marcus Maurer
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB139
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bef078f6bbfc1d9c6aff3ae7ccfc3a3
https://doi.org/10.1016/j.jaci.2022.12.434
https://doi.org/10.1016/j.jaci.2022.12.434
Autor:
Emel Aygören-Pürsün, Michael Manning, Olivier Fain, Bhavisha Desai, Dianne Tomita, Douglas Johnston, H. Henry Li, Sorena Kiani-Alikhan
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b49ecf698ea656dbb0ebe1e043f4508
https://doi.org/10.1016/j.jaci.2022.12.406
https://doi.org/10.1016/j.jaci.2022.12.406
Autor:
H. James Wedner, Raffi Tachdjian, Timothy Craig, Philip Collis, Bhavisha Desai, Dianne Tomita, Teresa Caballero
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa33b99b5e22faac48664a9ba14b9098
https://doi.org/10.1016/j.jaci.2021.12.543
https://doi.org/10.1016/j.jaci.2021.12.543
Autor:
Emel Aygoren-Pursun, Donald McNeil, Philip Collis, Bhavisha Desai, Dianne Tomita, Douglas Johnston
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cbbe077c679f6665cf0dc68d2089729
https://doi.org/10.1016/j.jaci.2021.12.544
https://doi.org/10.1016/j.jaci.2021.12.544
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::671652290ddd8d86a11685e8fc920157
https://doi.org/10.1016/j.jaci.2021.12.545
https://doi.org/10.1016/j.jaci.2021.12.545
Autor:
Sergey Orlov, Kaoru Kubota, Jesús Cárdenas Sánchez, Jin-Hyoung Kang, Li Zhang, Alexander N. Fleishman, Joseph K. Park, Vera Hirsh, Konstantinos N. Syrigos, Carlos H. Barrios, Gary Thomas, David H. Henry, Cisio De Oliveira Brandao, Tilman Steinmetz, Dianne Tomita, Pere Gascón, Martin Šmakal, Rajnish Nagarkar, David Gordon
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 15(2)
This study evaluated noninferiority of darbepoetin alfa versus placebo for overall survival (OS) and progression-free survival (PFS) in anemic patients with NSCLC treated to a 12.0-g/dL hemoglobin (Hb) ceiling.Adults with stage IV NSCLC expected to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e6825173ea32d5a6e5042671f9d1e4
https://pubmed.ncbi.nlm.nih.gov/32127181
https://pubmed.ncbi.nlm.nih.gov/32127181
Publikováno v:
Leukemia & Lymphoma. 57:283-290
Maintaining high relative dose intensity (RDI) is associated with improved outcomes, especially in patients with aggressive B-cell non-Hodgkin lymphoma (NHL). To evaluate changes in practice, we examined RDI, chemotherapy treatment patterns, dose del
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79e26c3b89b9e65f6b12cdc3308b333
https://doi.org/10.3109/10428194.2015.1045894
https://doi.org/10.3109/10428194.2015.1045894
Autor:
Volker Moebus, Michael Untch, Ulrike Nitz, Paolo Pronzato, Joyce O'Shaughnessy, Chet Bohac, Dianne Tomita, Matti Aapro, Brian Leyland-Jones
Publikováno v:
Annals of Oncology. 26:688-695
A meta-analysis of trials of ESA use in patients with breast cancer receiving chemotherapy was conducted. Nine studies were analyzed (ESAn = 2346; controln = 2367). The overall stratified random-effects odds ratio (95% CI) was 1.17 (0.99–1.39) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8ba995518ffaa55f1a1029b3705a14
https://doi.org/10.1093/annonc/mdu579
https://doi.org/10.1093/annonc/mdu579